Literature DB >> 19013378

Adverse drug reactions as a cause of hospital admissions: a 6-month experience in a single center in Greece.

Alexandra Alexopoulou1, Spyros P Dourakis, Demosthenes Mantzoukis, Thomas Pitsariotis, Anna Kandyli, Melanie Deutsch, Athanasios J Archimandritis.   

Abstract

BACKGROUND: Adverse drug reactions (ADRs) are a significant cause of morbidity and mortality.
METHODS: A prospective study was conducted over a 6-month period. All patients consecutively admitted were enrolled in the study. Analysis included: (1) an evaluation of the frequency of ADR-related hospital admissions and their causality, severity, and preventability; (2) a description of the type of drugs involved; (3) a report of the most common clinical manifestations related to these ADRs; and (4) an assessment of the factors that were predictive of ADRs.
RESULTS: Seventy of the 548 admissions (12.8%) were related to an ADR. Hemorrhage represented the most common ADR (37.3%), followed by metabolic and renal events (10.8% each). The drugs most often involved were non-steroid anti-inflammatory drugs (NSAIDs), followed by diuretics, aspirin, oral anticoagulants, and oral hypoglycemic agents. A comparison between ADR and non-ADR-related admissions showed that mean number of medications and age were significantly higher for patients admitted for an ADR than for those who were not. Gender, chronic disease at admission, days of hospitalization, cognitive impairment, renal insufficiency, physical activity impairment, and use of psychoactive drugs did not differ between the two groups. In the multivariate analysis, number of drugs was the only independent predictor of ADR-related hospital admission (OR=1.064, 95% CI 1.019-1.109). In 13 of 70 (18.6%) ADR-related hospital admissions, ADRs were coded as severe.
CONCLUSIONS: ADRs are common causes of hospital admissions and may have important consequences. The most important determinant for ADR-related hospital admissions is the number of drugs taken.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19013378     DOI: 10.1016/j.ejim.2007.06.030

Source DB:  PubMed          Journal:  Eur J Intern Med        ISSN: 0953-6205            Impact factor:   4.487


  50 in total

1.  Prescribed-drug utilization and polypharmacy in a general population in Greece: association with sociodemographic, health needs, health-services utilization, and lifestyle factors.

Authors:  E Pappa; N Kontodimopoulos; A A Papadopoulos; Y Tountas; D Niakas
Journal:  Eur J Clin Pharmacol       Date:  2010-11-11       Impact factor: 2.953

2.  Adverse drug reactions leading to urgent hospital admission in an elderly population: prevalence and main features.

Authors:  Consuelo Pedrós; Francesc Formiga; Xavier Corbella; Josep Maria Arnau
Journal:  Eur J Clin Pharmacol       Date:  2015-11-07       Impact factor: 2.953

3.  An observational study of glucocorticoid-induced osteoporosis prophylaxis in a national cohort of male veterans with rheumatoid arthritis.

Authors:  L Caplan; A E Hines; E Williams; A V Prochazka; K G Saag; F Cunningham; E Hutt
Journal:  Osteoporos Int       Date:  2010-04-01       Impact factor: 4.507

4.  The relationship between study characteristics and the prevalence of medication-related hospitalizations: a literature review and novel analysis.

Authors:  Anne J Leendertse; Djurre Visser; Antoine C G Egberts; Patricia M L A van den Bemt
Journal:  Drug Saf       Date:  2010-03-01       Impact factor: 5.606

Review 5.  Hospital admissions due to adverse drug reactions in the elderly. A meta-analysis.

Authors:  T J Oscanoa; F Lizaraso; Alfonso Carvajal
Journal:  Eur J Clin Pharmacol       Date:  2017-03-01       Impact factor: 2.953

Review 6.  Hospitalizations due to preventable adverse reactions-a systematic review.

Authors:  Nidhi S Patel; Tejas K Patel; Parvati B Patel; Viren N Naik; C B Tripathi
Journal:  Eur J Clin Pharmacol       Date:  2016-12-02       Impact factor: 2.953

7.  Potential drug interactions with dietary and herbal supplements during hospitalization.

Authors:  Ilana Levy; Samuel Attias; Eran Ben-Arye; Lee Goldstein; Elad Schiff
Journal:  Intern Emerg Med       Date:  2016-10-05       Impact factor: 3.397

8.  Medications Without Harm?

Authors:  Badriya Al-Zadjali; Bushra Al-Busaidi
Journal:  Oman Med J       Date:  2018-11

9.  Adverse drug reactions experience in a teaching hospital in Jordan.

Authors:  Mohammed Alsbou; Sameh Alzubiedi; Hamed Alzobi; Nawal Abu Samhadanah; Yousef Alsaraireh; Omar Alrawashdeh; Amin Aqel; Khalil Al-Salem
Journal:  Int J Clin Pharm       Date:  2015-08-19

10.  Trends of adverse drug reactions related-hospitalizations in Spain (2001-2006).

Authors:  Pilar Carrasco-Garrido; López Ana de Andrés; Valentín Hernández Barrera; Gil Angel de Miguel; Rodrigo Jiménez-García
Journal:  BMC Health Serv Res       Date:  2010-10-13       Impact factor: 2.655

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.